ST Pharm Co.,Ltd. (KOSDAQ:237690)
73,600
+1,900 (2.65%)
May 13, 2025, 3:30 PM KST
ST Pharm Revenue
In the year 2024, ST Pharm had annual revenue of 273.75B KRW, down -3.94%. ST Pharm had revenue of 115.74B in the quarter ending December 31, 2024, a decrease of -4.06%.
Revenue
273.75B
Revenue Growth
-3.94%
P/S Ratio
5.42
Revenue / Employee
417.94M
Employees
655
Market Cap
1,483.25B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 273.75B | -11.24B | -3.94% |
Dec 31, 2023 | 284.99B | 35.67B | 14.31% |
Dec 31, 2022 | 249.32B | 83.68B | 50.52% |
Dec 31, 2021 | 165.64B | 41.53B | 33.47% |
Dec 31, 2020 | 124.11B | 30.85B | 33.08% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,547.32B |
Celltrion | 3,557.30B |
ALTEOGEN | 102.85B |
Yuhan | 2,067.79B |
HLB Co., Ltd. | 68.13B |
SK Biopharmaceuticals | 547.60B |
PharmaResearch | 350.12B |
Peptron | 3.15B |